Rekha Hemrajani Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Rekha Hemrajani.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rekha Hemrajani. Rekha Hemrajani is a in Aravive, Inc. ($ARAV) and a President and CEO in Aravive, Inc. ($ARAV) and a Director in Adverum Biotechnologies, Inc. ($ADVM) and a See Remarks in Arcus Biosciences, Inc. ($RCUS) and a Director in ALX ONCOLOGY HOLDINGS INC ($ALXO).
Address: 3928 POINT EDEN WAY HAYWARD 94545 CA
Companies in which Rekha Hemrajani is an Insider
Adverum Biotechnologies, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Rekha Hemrajani: Director
Holdings: 0 shares
Latest Transaction: Jun 25 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ALX ONCOLOGY HOLDINGS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Rekha Hemrajani: Director
Holdings: 3,000 shares
Latest Transaction: Jul 21 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Aravive, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Rekha Hemrajani:
Holdings: 14,250 shares
Current Value: $189,525
Latest Transaction: Apr 09 2020
$ARAV Market Capitalization: $474.95M
$ARAV Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Arcus Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Rekha Hemrajani: See Remarks
Holdings: 0 shares
Latest Transaction: Mar 25 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Rekha Hemrajani
Sentiment: All, ADVM, ALXO, ARAV, RCUS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Hemrajani Rekha | Director | Buy | P | 19.00 | 3,000 | 57,000 | 3,000 | 0 to 3 K |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Hemrajani Rekha | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Apr 09 2020 | ARAV | Aravive, Inc. | Hemrajani Rekha | Sell | D | 0.00 | 42,750 | 0 | 14,250 | 57 K to 14.3 K (-75.00 %) | |
| Jan 09 2020 | ARAV | Aravive, Inc. | Hemrajani Rekha | President and CEO | Option Exercise | A | 13.77 | 143,000 | 1,969,110 | 143,000 | |
| Jan 09 2020 | ARAV | Aravive, Inc. | Hemrajani Rekha | President and CEO | Grant | A | 0.00 | 57,000 | 0 | 57,000 | 0 to 57 K |
| Aug 16 2019 | ADVM | Adverum Biotechnol ... | Hemrajani Rekha | Director | Option Exercise | A | 13.41 | 33,750 | 452,588 | 45,000 | |
| Aug 16 2019 | ADVM | Adverum Biotechnol ... | Hemrajani Rekha | Director | Option Exercise | A | 13.41 | 33,750 | 452,588 | 45,000 |